Owner @QareFree [self-employed]
Since October 2015
Interim- and project management in Life Sciences
Member Program Council 'Chemistry of Life'
September 2014 --- December 2015
December 2011 --- December 2015
Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic approaches using a cyclodextrin-based platform technology, with a focus on neglected and orphan diseases.
October 2011 --- September 2013
European patient organisation for neuromuscular disorders- providing an international platform for researchers and patient representatives to discuss the research agenda in neuromuscular diseases. Managing director of the organisation in Baarn, the Netherlands; responsible for operations and financial results of the foundation. ENMC hosted over 190 meetings and has a network of some 2500 researchers and patient representatives that have been collaborating in and contributing to these workshops. European NeuroMuscular Centre www.enmc.org
Director Clinical Research CNS (Anesthesia & Analgesia), MRL
November 2009 --- September 2011
Group Head, Global Clinical Research - responsible for global programs (US, EU and Japan) including paediatrics within therapy area; - leading clinical research group (science and operations incl. KOL interaction); - departmental MT member
Director Clinical Research CNS (Anesthesia & Analgesia), SPRI
November 2008 --- November 2009
Responsible for clinical part of submission and post-approval committment studies in USA, EU and Japan (sugammadex, Bridion) leading a team of clinical research scientists. Scientific lead for EU pediatric study program (6 studies) under PIP. Provide clinical input in PoC-paradigms for analgesia development candidates.
Clinical Group Director, Global Clinical Development [The Netherlands]
December 2004 --- November 2008
Responsible for phase 2 and 3 clinical development projects (Anesthesia & Analgesia) - leading a team of research scientists and project managers. Including successfull submissions in EU, Japan and USA and pediatric submissions (two PWR studies for FDA). Part of Schering-Plough as of November 2007
Director Development Projects [The Netherlands]
January 1999 --- November 2004
Global Project Director, leading (late-stage) global development projects (pre-clinical, clinical, cmc, regulatory and marketing) cross-functional and multi-cultural (global) teams, including clinical development teams. Therapeutic areas: anesthesia, analgesia/pain, oncology.
Head Analytical R&D [The Netherlands/France]
January 1997 --- January 1999
De-novo set-up and implementation of new this new department for Intervet Pharma R&D, including recruitment of new staff in France, training programs and laboratory design (Angers, Fr). Managing introduction of LC-MS-MS into veterinary bio-analytical studies.
Sr Project Manager [The Netherlands]
September 1989 --- December 1996
European CRO, providing bioanalytical and clinical laboratory services. Resposible for conduct of contracted studies for pharmaceutical companies (including clients such as Pfizer, Fujisawa, Roche), providing project management and scientific expertise. Real-time PK support for international Randomized, Concentration-Controlled Trial for CellCept (mycophenolate mofetil) involving 6 transplantation centres.
QA Manager [Basel, Switzerland]
August 1986 --- August 1989
Managing QC lab for ergot-alkaloid products; QP
in from HollandBio BioBusiness Masterclass in 2012
PhD in Analytical Chemistry from University of Twente in 1985
PharmD in Pharmacy from Leiden University in 1981